This type occurs when new vessels form to heal damaged tissue related to Dry AMD. However, the new vessels are very delicate and break easily, causing bleeding and damage to surrounding tissue. When one eye has wet macular degeneration there is about a 25% chance the other eye will become wet in five years.
The medication used to treat Wet AMD is just like any other medication. Consider for example, a person with high blood pressure who is prescribed a new medication. Upon returning to the doctor for a follow up, the blood pressure has returned back to normal. The patient then asks the doctor if he can stop the medication because his blood pressure is better. Unfortunately, for this patient the blood pressure is better because of the medication and it would increase again if the medication was stopped. Now there are examples of patients coming off of their blood pressure medications just as there are examples of patients eventually getting off of their treatment for wet AMD. This generally takes time and is not expected in every case.
As stated earlier, every eye is different and each case of macular degeneration is unique. Treatment is tailored to the specific drug used and the frequency of treatments. The maximum treatment frequency is an injection every four weeks. However, once the disease is controlled the treatment interval can be extended. We refer to this as “treat and extend”. One way to think about this is tapering off the medication: the interval between each treatment is slowly extended. As the interval between your injections increases, eventually there will be subtle changes and signs that indicate the disease is coming back. At this time, your doctor will either increase your injection frequency by one week and hold it at that interval or hold at your current treatment interval depending on what your exam demonstrates. This is referred to as “maintenance” and the goals are to maintain suppression of wet AMD activity.
For some patients, extending the interval between each treatment may not be the best option for vision. During treatment and extension, the interval between treatments is slowly increased until signs of recurrence appear. Then the treatment interval is shortened by one or two weeks and maintained. A patient with profound vision loss from AMD in one eye and getting treated in the other eye may not want to risk having the disease come back in their only good eye and possibly vision loss with extension. There are several other reasons and your doctor may discuss this with you when the time to increase the treatment interval arises. During these situations these patients are often treated at a fixed interval: they get an injection at a fixed interval of time and plan on keeping at that interval for life. This approach is referred to as a “fixed interval” treatment plan.